Information Provided By: 
Fly News Breaks for April 4, 2019
VAR
Apr 4, 2019 | 09:53 EDT
Barrington analyst Michael Petusky raised his price target for Varian Medical Systems to $150 from $135 after the company disclosed the initial preclinical results of its research on ultra-high dose cancer treatment utilizing protons at the American Association for Cancer Research meeting. The analyst views the early results as "encouraging" and adds that order momentum at Varian over the past several months "has been extremely strong." He keeps an Outperform rating on the shares.
News For VAR From the Last 2 Days
There are no results for your query VAR
